ZEVRA THERAPEUTICS, INC. (ZVRA) Insider Trading & SEC Filings
Last SEC filing
ZEVRA THERAPEUTICS, INC. (ZVRA) has filed 9 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-23. Insider sales over the same period: 2 transactions worth $459K. 2 Form 8-K material event filings were reported by ZVRA in the last 90 days. 2 Form 144 notices of proposed sale were filed for ZVRA stock. InsiderAlpha tracks every ZVRA SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About ZEVRA THERAPEUTICS, INC. (ZVRA)
ZEVRA THERAPEUTICS, INC. trades under the ticker ZVRA. InsiderAlpha tracks 26 primary SEC Form 4 filings from 14 reporting insiders for ZVRA since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001434647 |
90-Day SEC Filing Activity
| Insider sales (90d) | 2 ($459K) |
|---|---|
| Form 4 filings (90d) | 9 |
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 2 |
| Latest Form 4 filing | 2026-06-23 |
Recent ZVRA Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Rahsaan Thompson | Chief Legal & Compliance | S - Open-market sale [10b5-1] | 34.6K | $12.68 | $438K | SEC | |
| Rahsaan Thompson | Chief Legal & Compliance | M - Option exercise [10b5-1] | 66.7K | - | - | SEC | |
| Rahsaan Thompson | Chief Legal & Compliance | S - Open-market sale [10b5-1] | 1.8K | $11.30 | $20K | SEC | |
| John B. Bode | Director | M - Option exercise | 39.2K | $4.97 | $195K | SEC | |
| John B. Bode | Director | M - Option exercise | 39.2K | $4.89 | $192K | SEC | |
| Neil F. McFarlane | President and CEO | S - Open-market sale [10b5-1] | 14.6K | $8.56 | $125K | SEC | |
| Neil F. McFarlane | President and CEO | M - Option exercise [10b5-1] | 37.5K | - | - | SEC | |
| Timothy J. Sangiovanni | SVP, Finance & Corp Controller | S - Open-market sale [10b5-1] | 3.0K | $9.18 | $28K | SEC | |
| Joshua Schafer | CCO | S - Open-market sale [10b5-1] | 10.5K | $9.19 | $97K | SEC | |
| Neil F. McFarlane | President and CEO | S - Open-market sale [10b5-1] | 91.0K | $9.38 | $853K | SEC | |
| Joshua Schafer | CCO | M - Option exercise [10b5-1] | 35.3K | - | - | SEC | |
| Neil F. McFarlane | President and CEO | M - Option exercise [10b5-1] | 233.3K | - | - | SEC | |
| Timothy J. Sangiovanni | SVP, Finance & Corp Controller | M - Option exercise [10b5-1] | 11.7K | - | - | SEC | |
| Joshua Schafer | CCO | M - Option exercise [10b5-1] | 11.3K | - | - | SEC | |
| Timothy J. Sangiovanni | SVP, Finance & Corp Controller | M - Option exercise [10b5-1] | 6.3K | - | - | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for ZEVRA THERAPEUTICS, INC. (ZVRA). Updated in real time as new filings are submitted to the SEC.
Most-Active ZVRA Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Rahsaan Thompson | 4 | $459K |
| Timothy J. Sangiovanni | 2 | - |
| Corey Michael Watton | 1 | - |
| Douglas W. Calder | 1 | - |
| Alicia Secor | 1 | - |
Recent ZVRA Form 8-K Material Events
- - Item 5.07, 9.01 [SEC]
- - Item 2.02, 9.01 [SEC]
- - Item 1.01, 1.02, 7.01, 9.01 · Acquisition · mixed [SEC]
Zevra Therapeutics sold certain assets of its SDX portfolio, including AZSTARYS® and KP1077, to Commave Therapeutics for $50 million in cash. The transaction also resolves pending litigation between the parties related to their collaboration and license agreement. This represents - - Item 2.02, 5.02, 9.01 · Leadership · neutral [SEC]
Zevra Therapeutics appointed Justin Renz as Chief Financial Officer and Treasurer, effective March 9, 2026. The company also announced fourth quarter 2025 financial results and corporate updates via press release on the same date.
Recent ZVRA Form 144 Notices of Proposed Sale
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
Recent Insider Filings
- - Rahsaan Thompson (Chief Legal & Compliance)
- - Tamara A. Favorito (Director)
- - Alicia Secor (Director)
- - Corey Michael Watton (Director)
- - Douglas W. Calder (Director)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ZVRA insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
ZVRA Insider Trading - FAQ
- What is the latest insider trade for ZVRA?
- ZEVRA THERAPEUTICS, INC. (ZVRA) had 9 insider filings in the last 90 days, with the most recent on 2026-06-23. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying ZVRA stock?
- 0 insider purchases of ZVRA were filed in the last 90 days.
- How many insiders are selling ZVRA stock?
- 2 insider sales of ZVRA were filed in the last 90 days, totaling $459K.
- Where can I see ZVRA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks ZVRA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $ZYME Zymeworks Inc.
- $ABP Abpro Holdings, Inc.
- $AEMD AETHLON MEDICAL INC
- $AHCO AdaptHealth Corp.
- $AIM AIM ImmunoTech Inc.
- $AKTX Akari Therapeutics Plc
- $ALMS ALUMIS INC.
- $ANNX Annexon, Inc.
- $APGE Apogee Therapeutics, Inc.
- $APVO Aptevo Therapeutics Inc.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live ZVRA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.